Skin biomarkers predict development of atopic dermatitis in infancy
- PMID: 36112082
- DOI: 10.1111/all.15518
Skin biomarkers predict development of atopic dermatitis in infancy
Abstract
Background: There is currently no insight into biomarkers that can predict the onset of pediatric atopic dermatitis (AD).
Methods: Nested in a prospective birth cohort study that examined the occurrence of physician-diagnosed AD in 300 children, 44 random children with onset of AD in the first year of life were matched on sex and season of birth with 44 children who did not develop AD. Natural moisturizing factor (NMF), corneocyte surface protrusions, cytokines, free sphingoid bases (SBs) of different chain lengths and their ceramides were analyzed from tape strips collected at 2 months of age before onset of AD using liquid chromatography, atomic force microscopy, multiplex immunoassay, and liquid chromatography mass spectrometry, respectively.
Results: Significant alterations were observed for four lipid markers, with phytosphingosine ([P]) levels being significantly lower in children who developed AD compared with children who did not (median 240 pmol/mg vs. 540 pmol/mg, p < 0.001). The two groups of children differed in the relative amounts of SB of different chain lengths (C17, C18 and C20). Thymus- and activation-regulated chemokine (TARC/CCL17) was slightly higher in children who developed AD, whereas NMF and corneocyte surface texture were similar. AD severity assessed by the eczema area and severity index (EASI) at disease onset was 4.2 (2.0;7.2). [P] had the highest prediction accuracy among the biomarkers (75.6%), whereas the combination of 5 lipid ratios gave an accuracy of 89.4%.
Conclusion: This study showed that levels and SB chain length were altered in infants who later developed AD, and that TARC/CCL17 levels were higher.
Keywords: atopic dermatitis; biomarker; birth cohort; prediction; skin barrier.
© 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Comment in
-
Predicting the future: Early-life biomarkers of atopic dermatitis.J Allergy Clin Immunol. 2023 Jun;151(6):1479-1480. doi: 10.1016/j.jaci.2023.03.032. J Allergy Clin Immunol. 2023. PMID: 37286272 No abstract available.
References
REFERENCES
-
- Ravn NH, Halling AS, Berkowitz AG, et al. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis. J Allergy Clin Immunol. 2020;145(4):1182-1193. doi:10.1016/j.jaci.2019.12.899
-
- Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446. doi:10.1038/ng1767
-
- Chalmers JR, Haines RH, Bradshaw LE, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet (London, England). 2020;395(10228):962-972. doi:10.1016/s0140-6736(19)32984-8
-
- Foolad N, Brezinski EA, Chase EP, Armstrong AW. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol. 2013;149(3):350-355. doi:10.1001/jamadermatol.2013.1495
-
- Kezic S, Kemperman PM, Koster ES, et al. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol. 2008;128(8):2117-2119. doi:10.1038/jid.2008.29
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
